HK Stock MarketDetailed Quotes

01681 CONSUN PHARMA

Watchlist

8.950
+0.080+0.90%

Market Closed Mar 28 16:08 CST

7.60BMarket Cap7.74P/E (TTM)

CONSUN PHARMA Key Stats

Cash Flow

All

YOY

Hide blank lines

(FY)Dec 31, 2024

(Q6)Jun 30, 2024

(FY)Dec 31, 2023

(Q6)Jun 30, 2023

(FY)Dec 31, 2022

(Q6)Jun 30, 2022

(FY)Dec 31, 2021

(Q6)Jun 30, 2021

(FY)Dec 31, 2020

(Q6)Jun 30, 2020

Turnover

14.56%2.97B

13.30%1.27B

10.71%2.59B

12.70%1.12B

14.43%2.34B

12.07%993.53M

16.65%2.04B

15.76%886.53M

1.42%1.75B

-18.62%765.86M

Operating income

14.56%2.97B

13.30%1.27B

10.71%2.59B

12.70%1.12B

14.43%2.34B

12.07%993.53M

16.65%2.04B

15.76%886.53M

1.42%1.75B

-18.62%765.86M

Cost of sales

-8.48%-725.13M

-13.33%-321.03M

-15.90%-668.44M

-10.89%-283.26M

-11.48%-576.74M

-13.38%-255.44M

-19.98%-517.32M

-15.97%-225.29M

7.65%-431.16M

23.49%-194.27M

Operating expenses

-8.48%-725.13M

-13.33%-321.03M

-15.90%-668.44M

-10.89%-283.26M

-11.48%-576.74M

-13.38%-255.44M

-19.98%-517.32M

-15.97%-225.29M

7.65%-431.16M

23.49%-194.27M

Gross profit

16.67%2.24B

13.28%947.52M

9.01%1.92B

13.32%836.42M

15.42%1.76B

11.62%738.09M

15.56%1.53B

15.68%661.24M

4.78%1.32B

-16.82%571.59M

Selling expenses

-15.18%-981.58M

-13.78%-411.91M

-10.40%-852.21M

-10.57%-362.03M

-24.50%-771.96M

-18.28%-327.42M

-14.20%-620.04M

-23.55%-276.81M

-0.69%-542.93M

18.32%-224.04M

Administrative expenses

1.18%-311.87M

1.49%-134.71M

2.14%-315.6M

-1.07%-136.74M

-15.20%-322.5M

-31.87%-135.3M

-37.86%-279.96M

-16.87%-102.6M

-25.75%-203.07M

-8.66%-87.79M

Impairment and provision

-30.31%8.78M

-47.69%9.17M

-61.23%12.6M

37.08%17.53M

80.09%32.49M

850.22%12.79M

161.45%18.04M

109.28%1.35M

92.59%-29.36M

-48.67%-14.51M

-Other impairment is provision

-30.31%8.78M

-47.69%9.17M

-61.23%12.6M

37.08%17.53M

80.09%32.49M

850.22%12.79M

161.45%18.04M

109.28%1.35M

58.26%-29.36M

-48.67%-14.51M

Special items of operating profit

-26.05%87.63M

25.74%37.26M

110.16%118.5M

16.44%29.63M

-11.04%56.39M

-14.47%25.45M

7.75%63.38M

144.70%29.76M

3,954.91%58.83M

1,489.83%12.16M

Operating profit

18.09%1.05B

16.25%447.33M

16.85%884.97M

22.70%384.81M

6.85%757.33M

0.22%313.61M

17.12%708.77M

21.57%312.93M

271.92%605.14M

-19.92%257.41M

Financing cost

-17.04%-24.89M

-85.58%-13.38M

-94.49%-21.26M

-76.04%-7.21M

15.28%-10.93M

21.89%-4.09M

39.70%-12.91M

54.40%-5.24M

26.31%-21.4M

0.23%-11.49M

Share of profits of associates

---66K

----

Earning before tax

18.11%1.02B

14.92%433.96M

15.72%863.7M

22.00%377.61M

7.26%746.39M

0.59%309.52M

19.21%695.86M

25.12%307.69M

336.72%583.74M

-20.65%245.92M

Tax

-33.16%-102.73M

-10.82%-33M

-23.05%-77.15M

-114.56%-29.78M

42.35%-62.7M

77.90%-13.88M

-6.62%-108.74M

-28.91%-62.79M

-44.59%-101.99M

2.55%-48.7M

After-tax profit from continuing operations

16.63%917.37M

15.27%400.96M

15.04%786.55M

17.65%347.83M

16.45%683.7M

20.72%295.64M

21.87%587.12M

24.18%244.91M

663.19%481.74M

-24.13%197.21M

Earning after tax

16.63%917.37M

15.27%400.96M

15.04%786.55M

17.65%347.83M

16.45%683.7M

20.72%295.64M

21.87%587.12M

24.18%244.91M

663.19%481.74M

-24.13%197.21M

Minority profit

242.38%6.92M

1,967.19%1.2M

155.70%2.02M

94.12%-64K

125.86%790K

81.02%-1.09M

82.08%-3.06M

50.84%-5.74M

-2.08%-17.05M

-211.44%-11.67M

Profit attributable to shareholders

16.05%910.46M

14.91%399.77M

14.88%784.53M

17.24%347.89M

15.71%682.91M

18.39%296.73M

18.32%590.17M

19.99%250.64M

524.89%498.79M

-16.27%208.89M

Basic earnings per share

12.12%1.11

13.14%0.4987

15.12%0.99

17.77%0.4408

16.22%0.86

19.51%0.3743

21.31%0.74

23.94%0.3132

577.78%0.61

-13.72%0.2527

Diluted earnings per share

11.22%1.09

12.89%0.493

13.95%0.98

16.98%0.4367

17.81%0.86

19.76%0.3733

19.67%0.73

23.35%0.3117

577.78%0.61

-12.01%0.2527

Currency Unit

CNY

Accounting Standards

HKAS

Audit Opinions

Unqualified Opinion

Auditor

KPMG

	(FY)Dec 31, 2024	(Q6)Jun 30, 2024	(FY)Dec 31, 2023	(Q6)Jun 30, 2023	(FY)Dec 31, 2022	(Q6)Jun 30, 2022	(FY)Dec 31, 2021	(Q6)Jun 30, 2021	(FY)Dec 31, 2020	(Q6)Jun 30, 2020
Turnover	14.56%2.97B	13.30%1.27B	10.71%2.59B	12.70%1.12B	14.43%2.34B	12.07%993.53M	16.65%2.04B	15.76%886.53M	1.42%1.75B	-18.62%765.86M
Operating income	14.56%2.97B	13.30%1.27B	10.71%2.59B	12.70%1.12B	14.43%2.34B	12.07%993.53M	16.65%2.04B	15.76%886.53M	1.42%1.75B	-18.62%765.86M
Cost of sales	-8.48%-725.13M	-13.33%-321.03M	-15.90%-668.44M	-10.89%-283.26M	-11.48%-576.74M	-13.38%-255.44M	-19.98%-517.32M	-15.97%-225.29M	7.65%-431.16M	23.49%-194.27M
Operating expenses	-8.48%-725.13M	-13.33%-321.03M	-15.90%-668.44M	-10.89%-283.26M	-11.48%-576.74M	-13.38%-255.44M	-19.98%-517.32M	-15.97%-225.29M	7.65%-431.16M	23.49%-194.27M
Gross profit	16.67%2.24B	13.28%947.52M	9.01%1.92B	13.32%836.42M	15.42%1.76B	11.62%738.09M	15.56%1.53B	15.68%661.24M	4.78%1.32B	-16.82%571.59M
Selling expenses	-15.18%-981.58M	-13.78%-411.91M	-10.40%-852.21M	-10.57%-362.03M	-24.50%-771.96M	-18.28%-327.42M	-14.20%-620.04M	-23.55%-276.81M	-0.69%-542.93M	18.32%-224.04M
Administrative expenses	1.18%-311.87M	1.49%-134.71M	2.14%-315.6M	-1.07%-136.74M	-15.20%-322.5M	-31.87%-135.3M	-37.86%-279.96M	-16.87%-102.6M	-25.75%-203.07M	-8.66%-87.79M
Impairment and provision	-30.31%8.78M	-47.69%9.17M	-61.23%12.6M	37.08%17.53M	80.09%32.49M	850.22%12.79M	161.45%18.04M	109.28%1.35M	92.59%-29.36M	-48.67%-14.51M
-Other impairment is provision	-30.31%8.78M	-47.69%9.17M	-61.23%12.6M	37.08%17.53M	80.09%32.49M	850.22%12.79M	161.45%18.04M	109.28%1.35M	58.26%-29.36M	-48.67%-14.51M
Special items of operating profit	-26.05%87.63M	25.74%37.26M	110.16%118.5M	16.44%29.63M	-11.04%56.39M	-14.47%25.45M	7.75%63.38M	144.70%29.76M	3,954.91%58.83M	1,489.83%12.16M
Operating profit	18.09%1.05B	16.25%447.33M	16.85%884.97M	22.70%384.81M	6.85%757.33M	0.22%313.61M	17.12%708.77M	21.57%312.93M	271.92%605.14M	-19.92%257.41M
Financing cost	-17.04%-24.89M	-85.58%-13.38M	-94.49%-21.26M	-76.04%-7.21M	15.28%-10.93M	21.89%-4.09M	39.70%-12.91M	54.40%-5.24M	26.31%-21.4M	0.23%-11.49M
Share of profits of associates	---66K	----	----	----	----	----	----	----	----	----
Earning before tax	18.11%1.02B	14.92%433.96M	15.72%863.7M	22.00%377.61M	7.26%746.39M	0.59%309.52M	19.21%695.86M	25.12%307.69M	336.72%583.74M	-20.65%245.92M
Tax	-33.16%-102.73M	-10.82%-33M	-23.05%-77.15M	-114.56%-29.78M	42.35%-62.7M	77.90%-13.88M	-6.62%-108.74M	-28.91%-62.79M	-44.59%-101.99M	2.55%-48.7M
After-tax profit from continuing operations	16.63%917.37M	15.27%400.96M	15.04%786.55M	17.65%347.83M	16.45%683.7M	20.72%295.64M	21.87%587.12M	24.18%244.91M	663.19%481.74M	-24.13%197.21M
Earning after tax	16.63%917.37M	15.27%400.96M	15.04%786.55M	17.65%347.83M	16.45%683.7M	20.72%295.64M	21.87%587.12M	24.18%244.91M	663.19%481.74M	-24.13%197.21M
Minority profit	242.38%6.92M	1,967.19%1.2M	155.70%2.02M	94.12%-64K	125.86%790K	81.02%-1.09M	82.08%-3.06M	50.84%-5.74M	-2.08%-17.05M	-211.44%-11.67M
Profit attributable to shareholders	16.05%910.46M	14.91%399.77M	14.88%784.53M	17.24%347.89M	15.71%682.91M	18.39%296.73M	18.32%590.17M	19.99%250.64M	524.89%498.79M	-16.27%208.89M
Basic earnings per share	12.12%1.11	13.14%0.4987	15.12%0.99	17.77%0.4408	16.22%0.86	19.51%0.3743	21.31%0.74	23.94%0.3132	577.78%0.61	-13.72%0.2527
Diluted earnings per share	11.22%1.09	12.89%0.493	13.95%0.98	16.98%0.4367	17.81%0.86	19.76%0.3733	19.67%0.73	23.35%0.3117	577.78%0.61	-12.01%0.2527
Currency Unit	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY	CNY
Accounting Standards	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS	HKAS
Audit Opinions	--	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--	Unqualified Opinion	--
Auditor	--	--	KPMG	--	KPMG	--	KPMG	--	KPMG	--

FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.

Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.

Market Insights